Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Optical tomographic imaging of near infrared imaging agents quantifies disease severity and immunomodulation of experimental autoimmune encephalomyelitis in vivo.
[Neurological manifestations of Behçet's disease.]
Occurrence of adverse events in chronic intrathecal baclofen infusion: a one-year follow-up study of 158 adults.
[Relationship between the levels and variation of CXCL12, PDGF, CXCL14 in cerebrospinal fluid of optic neuritis and neuromyelitis optica].
Effect of Fingolimod on Platelet Count Among Multiple Sclerosis Patients.
Origins of oligodendrocytes in the cerebellum, whose development is controlled by the transcription factor, Sox9.
How are cognitive impairment, fatigue and signs of depression related to participation in daily life among persons with multiple sclerosis?
Teriflunomide and its mechanism of action in multiple sclerosis.
Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group.
How to make an oligodendrocyte.
Monoclonal Antibodies for Multiple Sclerosis Treatment.
Purines in neurodegeneration and neuroregeneration.
Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumab.
Quantitative magnetic resonance imaging of cortical multiple sclerosis pathology.
Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
Autoimmune diseases and reproductive aging.
The role of chromogranin B in an animal model of multiple sclerosis.
Interferon Beta and Long-term Disability in Multiple Sclerosis.
Neutrophil-related factors as biomarkers in EAE and MS.
The relationship between regional microstructural abnormalities of the corpus callosum and physical and cognitive disability in relapsing-remitting multiple sclerosis.
Natalizumab analogon therapy is effective in a B cell-dependent multiple sclerosis model.
Effectiveness of telerehabilitation interventions in persons with multiple sclerosis: A systematic review.
The effect of rhythmic-cued motor imagery on walking, fatigue and quality of life in people with multiple sclerosis: A randomised controlled trial.
Cerebrospinal fluid oligoclonal IgG bands in multiple sclerosis: what does it mean?
Aquaporin 4 Expression and Tissue Susceptibility to Neuromyelitis Optica.
Pages
« first
‹ previous
…
482
483
484
485
486
487
488
489
490
…
next ›
last »